REG - Wellnex Life Limited - Update on loan repayment

Wellnex LifeAnnouncement

21/04/2026 08:16

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260421:nRSU2936Ba&default-theme=true

RNS Number : 2936B  Wellnex Life Limited  21 April 2026

ASX/AIM Announcement

 
 
 
21 April 2026

Update on loan repayment

Wellnex Life Limited (ASX/AIM: WNX) ("Wellnex Life" or the "Company")
announces an update to the previously announced repayment of the loans to
former directors totalling $2.88m (including interest), which were due for
repayment by 20 April 2026. The Company and the former directors are in
advanced discussions on agreeing an extension to the previously agreed
deadlines and an update will be issued shortly.

This ASX/AIM announcement has been authorised by the Board of Wellnex Life
Limited (ASX/AIM:WNX).

The information contained within this announcement is deemed by the Company to
constitute inside information pursuant to article 7 of EU Regulation 596/2014
as it forms part of UK domestic law by virtue of the European Union
(Withdrawal) Act 2018 as amended.

--- END ---

For further information, please contact:

Wellnex Life Limited (ASX/AIM:WNX)
 

Eric Jiang
 

Interim Executive
Chairman

E: eric.j@wellnexlife.com.au (mailto:eric.j@wellnexlife.com.au)

 

UK Investors

Strand Hanson (Financial & Nominated Advisor)

 

James Harris / Richard Johnson
                                     Tel:
+44 (0) 20 7409 3494

 

Orana Corporate LLP (Joint
Broker)
swykeham@oranacorp.com (mailto:swykeham@oranacorp.com)

Sebastian Wykeham

 

S.P. Angel Corporate Finance LLP (Joint Broker)        Tel: +44 (0)20
3470 0470

David Hignell / Vadim Alexandre

 

To learn more, please visit: https://wellnexlife.com.au/
(https://wellnexlife.com.au/)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFIFIDSSILFIR



            Copyright 2019 Regulatory News Service, all rights reserved